Hidden Immunotherapy Targets Challenge Dogma

Tekijä Ferrone, Soldano
Julkaistu 2011

Tumor escape mechanisms: Potential role of soluble HLA antigens and NK cells activating ligands

Tekijä Campoli, Michael, Ferrone, Soldano
Julkaistu 2008

HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance

Tekijä Campoli, Michael, Ferrone, Soldano
Julkaistu 2008

HLA antigen and NK cell activating ligand expression in malignant cells: a story of loss or acquisition

Tekijä Campoli, Michael, Ferrone, Soldano
Julkaistu 2011

Improving the clinical significance of preclinical immunotherapy studies through incorporating tumor microenvironment-like conditions

Tekijä Maggs, Luke, Ferrone, Soldano
Julkaisussa Clin Cancer Res (2020)

Cancer immunotherapy: Progress and challenges in the clinical setting

Tekijä Zarour, Hassane M., Ferrone, Soldano
Julkaistu 2011

For Breast Cancer Prognosis, Immunoglobulin Kappa Chain Surfaces to the Top

Tekijä Whiteside, Theresa L., Ferrone, Soldano
Julkaistu 2012

HLA class II antigen-processing pathway in tumors: Molecular defects and clinical relevance

Tekijä Seliger, Barbara, Kloor, Matthias, Ferrone, Soldano
Julkaisussa Oncoimmunology (2017)

Rewarding patient-directed research: Excellence in Translational Medicine Award

Tekijä Marincola Francesco M, Ferrone Soldano, Brander Christian
Julkaistu 2006-05-01

Rewarding patient-directed research: Excellence in Translational Medicine Award

Tekijä Brander, Christian, Ferrone, Soldano, Marincola, Francesco M
Julkaistu 2006

Soluble HLA-G: Are They Clinically Relevant?

Tekijä Pistoia, Vito, Morandi, Fabio, Wang, Xinhui, Ferrone, Soldano
Julkaistu 2007

Monoclonal Antibodies for Cancer Immunotherapy

Tekijä Weiner, Louis M., Dhodapkar, Madhav V., Ferrone, Soldano
Julkaistu 2009

Immunotherapy of malignant disease with tumor antigen (TA)-specific monoclonal antibodies: does its therapeutic efficacy require cooperation with TA-specific CTL?

Tekijä Campoli, Michael, Ferris, Robert, Ferrone, Soldano, Wang, Xinhui
Julkaistu 2009

Tumor Antigen–Targeted, Monoclonal Antibody–Based Immunotherapy: Clinical Response, Cellular Immunity, and Immunoescape

Tekijä Ferris, Robert L., Jaffee, Elizabeth M., Ferrone, Soldano
Julkaistu 2010

The complex role of B7 molecules in tumor immunology

Tekijä Seliger, Barbara, Marincola, Francesco M., Ferrone, Soldano, Abken, Hinrich
Julkaistu 2008

Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?

Tekijä Amiot, Laurence, Ferrone, Soldano, Grosse-Wilde, Hans, Seliger, Barbara
Julkaistu 2010

Chondroitin Sulfate Proteoglycan-4 (CSPG4)-Specific Monoclonal Antibody 225.28 in Detection of Acute Myeloid Leukemia Blasts

Tekijä Fenton, Moon, Whiteside, Theresa L., Ferrone, Soldano, Boyiadzis, Michael
Julkaisussa Oncol Res (2015)

Lost in Translation: Obstacles to Translational Medicine

Tekijä Mankoff, Stacey P, Brander, Christian, Ferrone, Soldano, Marincola, Francesco M
Julkaistu 2004

Interferon-γ Secretion by t(9;22) Acute Lymphoblastic Leukemia-Derived Dendritic Cells

Tekijä Brady, Michael T., Lee, Jaewoo, Ferrone, Soldano, Wang, Eunice S., Wetzler, Meir
Julkaistu 2010

IMMUNOREGULATORY PROPERTIES OF CD44+ CANCER STEM-LIKE CELLS IN SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK

Tekijä Chikamatsu, Kazuaki, Takahashi, Goro, Sakakura, Koichi, Ferrone, Soldano, Masuyama, Keisuke
Julkaistu 2011